Skip navigation
Perelman School of Medicine at the University of Pennsylvania gtp-logo_ColorKnockoutNavy GENE THERAPY PROGRAM Navigate to home page
  • Home
  • About Us
  • The Wilson Lab
  • Vector Core
  • Our Team
  • News
  • Publications
  • Careers
  • Contact

Filter by year:

  • 2009
  • 2011

Filter by author:

  • Betts MR
  • Brantly M
  • Brantly ML
  • Byrne BJ
  • Calcedo R
  • Campbell-Thompson M
  • Carey B
  • Chulay JD
  • Conlon TJ
  • Flotte TR
  • Humphries M
  • Knop DR
  • McElvaney NG
  • Messina LM
  • Mueller C
  • Deselect Rouhani F
  • Sandhaus RA
  • Spencer C
  • Spencer LT
  • Trapnell BC
  • Wang L
  • Wilson JM
  • Yachnis AT
  • Ye GJ

Publication 10/01/2011

Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim results.

Flotte TR, Trapnell BC, Humphries M, Carey B, Calcedo R, Rouhani F, Campbell-Thompson M, Yachnis AT, Sandhaus RA, McElvaney NG, Mueller C, Messina LM, Wilson JM, Brantly M, Knop DR, Ye GJ, Chulay JD

Human Gene Therapy

Publication 9/22/2009

Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy.

Brantly ML, Chulay JD, Wang L, Mueller C, Humphries M, Spencer LT, Rouhani F, Conlon TJ, Calcedo R, Betts MR, Spencer C, Byrne BJ, Wilson JM, Flotte TR

Proceedings Of The National Academy Of Sciences Of The United States Of America